Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Natural History and Outcome Measure Discovery Study of Neuronal Ceroid Lipofuscinosis Type 5 (CLN5)

NCT03822650 is registered in ClinicalTrials.gov with Neurogene Inc. as lead sponsor.

NCT NCT03822650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03822650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Natural History and Outcome Measure Discovery Study of Neuronal Ceroid Lipofuscinosis Type 5 (CLN5)
Lead sponsor
Neurogene Inc.
Phase
Observational
Overall status
Completed
Start date
March 13, 2019
Completion date
May 30, 2024
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ceroid lipofuscinosis, neuronal 5